• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

472 例乳腺癌易感患者的 BRCA1/2 基因和 8 个候选基因中罕见的种系大片段重排。

Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.

机构信息

Laboratoire d'Oncogénétique, Institut Curie-Hôpital René Huguenin, 35 rue Dailly, 92210 Saint-Cloud, France.

出版信息

Breast Cancer Res Treat. 2012 Jun;133(3):1179-90. doi: 10.1007/s10549-012-2009-5. Epub 2012 Apr 5.

DOI:10.1007/s10549-012-2009-5
PMID:22476849
Abstract

Hereditary breast cancers account for up to 5-10 % of breast cancers and a majority are related to the BRCA1 and BRCA2 genes. However, many families with breast cancer predisposition do not carry any known mutations for BRCA1 and BRCA2 genes. We explored the incidence of rare large rearrangements in the coding, noncoding and flanking regions of BRCA1/2 and in eight other candidate genes--CHEK2, BARD1, ATM, RAD50, RAD51, BRIP1, RAP80 and PALB2. A dedicated zoom-in CGH-array was applied to screen for rearrangements in 472 unrelated French individuals from breast-ovarian cancer families that were being followed in eight French oncogenetic laboratories. No new rearrangement was found neither in the genomic regions of BRCA1/2 nor in candidate genes, except for the CHEK2 and BARD1 genes. Three heterozygous deletions were detected in the 5' and 3' flanking regions of BRCA1. One large deletion introducing a frameshift was identified in the CHEK2 gene in two families and one heterozygous deletion was detected within an intron of BARD1. The study demonstrates the usefulness of CGH-array in routine genetic analysis and, aside from the CHEK2 rearrangements, indicates there is a very low incidence of large rearrangements in BRCA1/2 and in the other eight candidate genes in families already explored for BRCA1/2 mutations. Finally, next-generation sequencing should bring new information about point mutations in intronic and flanking regions and also medium size rearrangements.

摘要

遗传性乳腺癌占乳腺癌的 5-10%,其中大多数与 BRCA1 和 BRCA2 基因有关。然而,许多有乳腺癌易感性的家族并没有携带 BRCA1 和 BRCA2 基因的已知突变。我们探讨了 BRCA1/2 的编码区、非编码区和侧翼区以及其他八个候选基因-CHEK2、BARD1、ATM、RAD50、RAD51、BRIP1、RAP80 和 PALB2 中罕见的大片段重排的发生率。我们应用专用的 CGH 微阵列对 472 名来自乳腺癌-卵巢癌家族的、在 8 个法国肿瘤遗传学实验室接受随访的无关联法国个体进行筛查,以寻找重排。除了 CHEK2 和 BARD1 基因外,在 BRCA1/2 和候选基因的基因组区域中均未发现新的重排。在 BRCA1 的 5'和 3'侧翼区域检测到 3 个杂合性缺失。在两个家族中,在 CHEK2 基因中发现了一个引入移码的大片段缺失,在 BARD1 的内含子中检测到一个杂合性缺失。该研究证明了 CGH 微阵列在常规遗传分析中的有用性,除了 CHEK2 重排外,还表明在已经探索过 BRCA1/2 突变的家族中,BRCA1/2 和其他八个候选基因中大片段重排的发生率非常低。最后,下一代测序应该会提供关于内含子和侧翼区域点突变以及中等大小重排的新信息。

相似文献

1
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition.472 例乳腺癌易感患者的 BRCA1/2 基因和 8 个候选基因中罕见的种系大片段重排。
Breast Cancer Res Treat. 2012 Jun;133(3):1179-90. doi: 10.1007/s10549-012-2009-5. Epub 2012 Apr 5.
2
BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.在意大利男性乳腺癌病例中,BRCA1/BRCA2重排和CHEK2常见突变并不常见。
Breast Cancer Res Treat. 2008 Jul;110(1):161-7. doi: 10.1007/s10549-007-9689-2. Epub 2007 Jul 28.
3
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene.在捷克高危乳腺癌/卵巢癌患者的 BRCA1 和 BRCA2 基因中筛查基因组重排:BRCA1 基因中存在高比例的群体特异性改变。
Breast Cancer Res Treat. 2010 Nov;124(2):337-47. doi: 10.1007/s10549-010-0745-y. Epub 2010 Feb 5.
4
Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.丹麦高危乳腺癌-卵巢癌家族中BRCA1和BRCA2基因的大片段重排
Breast Cancer Res Treat. 2009 May;115(2):315-23. doi: 10.1007/s10549-008-0088-0. Epub 2008 Jun 12.
5
BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.波兰北部乳腺癌和卵巢癌家族中BRCA1和BRCA2基因的点突变及大片段重排
Oncol Rep. 2008 Jan;19(1):263-8.
6
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.乳腺癌高危家族中BRCA1、BRCA2、CHEK2和TP53的突变谱。
JAMA. 2006 Mar 22;295(12):1379-88. doi: 10.1001/jama.295.12.1379.
7
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia.斯洛伐克遗传性乳腺癌/卵巢癌家系的综合遗传特征分析。
Breast Cancer Res Treat. 2011 Feb;126(1):119-30. doi: 10.1007/s10549-010-1325-x. Epub 2011 Jan 4.
8
BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants.乌拉圭乳腺癌和乳腺癌-卵巢癌家族的 BRCA1 和 BRCA2 种系突变。新突变和未分类变异体的鉴定。
Breast Cancer Res Treat. 2011 Jul;128(1):211-8. doi: 10.1007/s10549-010-1320-2. Epub 2010 Dec 29.
9
Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families.在阿什肯纳兹族乳腺癌和卵巢癌家族中未发现基因组 BRCA1 和 BRCA2 重排。
Breast Cancer Res Treat. 2010 Sep;123(2):581-5. doi: 10.1007/s10549-010-0818-y. Epub 2010 Mar 11.
10
Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.在高危芬兰 BRCA1/2 种系突变阴性的乳腺癌和/或卵巢癌个体中筛查 BRCA1、BRCA2、CHEK2、PALB2、BRIP1、RAD50 和 CDH1 突变。
Breast Cancer Res. 2011 Feb 28;13(1):R20. doi: 10.1186/bcr2832.

引用本文的文献

1
Adaptive nanopore sequencing to determine pathogenicity of exonic duplication.自适应纳米孔测序确定外显子重复的致病性。
J Med Genet. 2023 Nov 27;60(12):1206-1209. doi: 10.1136/jmg-2023-109155.
2
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.通过连锁研究对 101 个意义未明的 BRCA1 和 BRCA2 变异进行分类:一种强大的方法。
Am J Hum Genet. 2021 Oct 7;108(10):1907-1923. doi: 10.1016/j.ajhg.2021.09.003. Epub 2021 Sep 30.
3
5' Region Large Genomic Rearrangements in the Gene in French Families: Identification of a Tandem Triplication and Nine Distinct Deletions with Five Recurrent Breakpoints.
法裔家族中该基因5'区域的大基因组重排:串联三倍体的鉴定以及具有五个反复出现断点的九个不同缺失。
Cancers (Basel). 2021 Jun 25;13(13):3171. doi: 10.3390/cancers13133171.
4
Literature Review of as a Cancer Predisposing Gene with a Focus on Breast and Ovarian Cancers.作为一种致癌基因的文献综述,重点关注乳腺癌和卵巢癌。
Genes (Basel). 2020 Jul 27;11(8):856. doi: 10.3390/genes11080856.
5
in Breast and Ovarian Cancers.在乳腺癌和卵巢癌中。
Int J Mol Sci. 2020 May 28;21(11):3850. doi: 10.3390/ijms21113850.
6
is A Low/Moderate Breast Cancer Risk Gene: Evidence Based on An Association Study of the Central European p.Q564X Recurrent Mutation.是一种低/中度乳腺癌风险基因:基于中欧p.Q564X复发性突变关联研究的证据
Cancers (Basel). 2019 May 28;11(6):740. doi: 10.3390/cancers11060740.
7
Germline Missense Variants in : New Trends and Challenges for Clinical Annotation.中的种系错义变体:临床注释的新趋势与挑战
Cancers (Basel). 2019 Apr 12;11(4):522. doi: 10.3390/cancers11040522.
8
Characterization of potential driver mutations involved in human breast cancer by computational approaches.通过计算方法对人类乳腺癌中潜在驱动突变的特征分析。
Oncotarget. 2017 Jul 25;8(30):50252-50272. doi: 10.18632/oncotarget.17225.
9
Genomic rearrangement screening of the from seventy Iranian high-risk breast cancer families.对来自70个伊朗高危乳腺癌家族的(此处原文不完整,缺少具体所指对象)进行基因组重排筛查。
J Res Med Sci. 2016 Nov 2;21:95. doi: 10.4103/1735-1995.193167. eCollection 2016.
10
New challenges for BRCA testing: a view from the diagnostic laboratory.BRCA检测面临的新挑战:来自诊断实验室的视角
Eur J Hum Genet. 2016 Sep;24 Suppl 1(Suppl 1):S10-8. doi: 10.1038/ejhg.2016.94.